Edition:
United Kingdom

Kalvista Pharmaceuticals Inc (KALV.OQ)

KALV.OQ on NASDAQ Stock Exchange Global Market

16.71USD
18 Jan 2019
Change (% chg)

$-1.44 (-7.93%)
Prev Close
$18.15
Open
$18.16
Day's High
$18.25
Day's Low
$16.25
Volume
30,667
Avg. Vol
24,013
52-wk High
$25.57
52-wk Low
$7.74

Chart for

About

KalVista Pharmaceuticals, Inc., formerly Carbylan Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The Company has developed a portfolio of small molecule plasma kallikrein... (more)

Overall

Beta: --
Market Cap(Mil.): $70.42
Shares Outstanding(Mil.): 9.71
Dividend: --
Yield (%): --

Financials

  KALV.OQ Industry Sector
P/E (TTM): -- 30.48 33.71
EPS (TTM): -3.21 -- --
ROI: -60.80 14.98 14.48
ROE: -61.05 16.31 15.99

Earnings vs. Estimates